We did the Stomach cancer Adjuvant Multi-Institutional group Trial ( SAMIT ) to assess the superiority of sequential treatment ( paclitaxel then tegafur and uracil -LSB- UFT -RSB- or paclitaxel then S-@ ) compared with monotherapy ( UFT or S-@ ) and also the non-inferiority of UFT compared with S-@ .